Skip to main content

Table 2 Effect allele frequencies (EAFs) of 31 late age-related macular degeneration related single nucleotide polymorphisms in East Asian groups including Koreans

From: Comparison of risk allele frequencies of single nucleotide polymorphisms associated with age-related macular degeneration in different ethnic groups

SNP ID

Chr

Position

Function

Ref allele

Alt

allele

Nearby/containing Gene

Global East Asian EAF

CHS EAF

CHS log10 P

CDX EAF

CDX log10 P

KHV EAF

KHV log10 P

CHB EAF

CHB log10 P

JPT EAF

JPT log10 P

KOR EAF

KOR log10 P

rs10033900

chr4

110,659,067

intergenic

T

C

CFI

0.39

0.39

0.00

0.45

0.92

0.43

0.65

0.31

−1.72

0.37

−0.24

0.34

−2.17

rs10781182

chr9

76,617,720

intergenic

T

G

MIR6130/RORB

0.49

0.51

0.01

0.54

0.50

0.49

0.02

0.50

0.00

0.41

−0.81

0.41

−3.69

rs10922109

chr1

196,704,632

intronic

C

A

CFH

0.44

0.46

0.00

0.51

0.67

0.40

−0.27

0.38

−0.57

0.47

0.19

0.47

0.89

rs11080055

chr17

26,649,724

intronic

A

C

TMEM97/VTN

0.72

0.80

0.77

0.63

−1.03

0.63

−0.99

0.74

0.08

0.77

0.54

0.76

1.50

rs1142

chr7

104,756,326

downstream

C

T

KMT2E/SRPK2

0.37

0.35

0.00

0.47

1.03

0.39

0.20

0.37

0.00

0.26

−1.61

0.34

−1.03

rs11884770

chr2

228,086,920

ncRNA_intronic

T

C

COL4A3

0.78

0.78

0.00

0.81

0.28

0.84

0.72

0.76

−0.13

0.73

−0.56

0.76

−0.43

rs12019136

chr19

5,835,677

intronic

G

A

C3

0.14

0.08

−0.69

0.29

4.20

0.21

0.99

0.10

−0.42

0.04

−3.29

0.08

−6.61

rs12357257

chr10

24,999,593

intronic

G

A

ARHGAP21

0.05

0.02

−0.65

0.11

1.37

0.08

0.47

0.02

−0.79

0.03

−0.35

0.03

−1.70

rs13081855

chr3

99,481,539

ncRNA_intronic

G

T

COL8A1/FILIP1L

0.05

0.04

−0.01

0.05

0.00

0.07

0.35

0.05

0.06

0.03

−0.22

0.03

−2.17

rs1626340

chr9

101,923,372

intergenic

G

A

TGFBR1/COL15A1

0.46

0.38

−0.69

0.53

0.67

0.38

−0.72

0.50

0.37

0.52

0.60

0.51

2.17

rs181705462

chr6

31,947,027

intronic

G

T

C2/CFB/SKIV2L

0.00

0.00

0.00

0.00

0.00

0.01

0.20

0.01

0.40

0.00

0.00

0.00

−0.13

rs2043085

chr15

58,680,954

intergenic

T

C

AQP9;LIPC

0.50

0.55

0.35

0.52

0.13

0.55

0.35

0.52

0.13

0.38

−1.85

0.48

−0.43

rs2230199

chr19

6,718,387

exonic

G

C

C3

0.00

0.00

−0.67

0.00

−0.75

0.01

0.20

0.01

0.79

0.00

−0.81

0.00

− 0.93

rs2740488

chr9

107,661,742

intronic

A

C

ABCA1

0.24

0.26

0.01

0.25

0.02

0.20

−0.35

0.22

−0.13

0.29

0.55

0.26

0.45

rs3138141

chr12

56,115,778

ncRNA_intronic

C

A

RDH5/CD63/MMP19

0.12

0.12

0.00

0.16

0.66

0.19

0.99

0.09

−0.33

0.04

−2.42

0.07

−5.43

rs3750846

chr10

124,215,565

intronic

T

C

ARMS2/HTRA1

0.41

0.39

−0.01

0.40

0.00

0.41

0.00

0.43

0.08

0.40

0.00

0.42

0.14

rs429358

chr19

45,411,941

exonic

T

C

APOE

0.09

0.06

−0.29

0.10

0.22

0.09

0.08

0.10

0.13

0.08

0.00

0.09

0.18

rs55975637

chr3

99,419,853

ncRNA_intronic

G

A

COL8A1

0.06

0.06

0.00

0.06

0.02

0.09

0.45

0.05

0.00

0.03

−0.53

0.03

−3.03

rs570618

chr1

196,657,064

intronic

T

G

CFH

0.95

0.96

0.01

0.98

0.66

0.96

0.11

0.93

−0.42

0.93

−0.35

0.92

−2.17

rs5754227

chr22

33,105,817

intronic

T

C

SYN3/TIMP3

0.61

0.63

0.01

0.55

−0.57

0.65

0.21

0.56

−0.40

0.67

0.62

0.67

2.97

rs61818925

chr1

196,815,450

intergenic

T

G

CFHR1

0.41

0.33

−0.69

0.32

−0.92

0.48

0.70

0.46

0.37

0.46

0.46

0.50

5.24

rs61985136

chr14

68,769,199

intronic

C

T

RAD51B

0.45

0.40

−0.26

0.51

0.59

0.49

0.27

0.38

−0.75

0.47

0.16

0.42

−0.93

rs62247658

chr3

64,715,155

ncRNA_intronic

C

T

ADAMTS9-AS2

0.24

0.25

0.00

0.31

0.75

0.31

0.78

0.19

−0.42

0.17

− 0.81

0.20

−1.70

rs6565597

chr17

79,526,821

intronic

C

T

NPLOC4/TSPAN10

0.21

0.17

−0.36

0.24

0.24

0.23

0.15

0.18

−0.15

0.22

0.01

0.21

0.03

rs67538026

chr19

1,031,438

intronic

C

T

CNN2

0.52

0.47

−0.29

0.57

0.46

0.49

−0.20

0.44

−0.79

0.62

1.12

0.50

−0.64

rs72802342

chr16

75,234,872

intergenic

C

A

CTRB2/CTRB1

0.13

0.12

0.00

0.20

1.03

0.16

0.30

0.11

−0.13

0.09

−0.65

0.11

−0.75

rs73036519

chr19

45,748,362

intergenic

G

C

EXOC3L2/MARK4

0.00

0.00

0.00

0.00

0.00

0.01

0.27

0.00

0.00

0.00

0.00

0.00

−0.35

rs7803454

chr7

99,991,548

intronic

C

T

PILRB/PILRA

0.03

0.03

0.00

0.02

−0.23

0.06

0.72

0.01

−0.40

0.03

0.00

0.02

−0.40

rs8135665

chr22

38,476,276

intronic

C

T

SLC16A8

0.14

0.09

−1.02

0.23

2.55

0.19

0.99

0.10

−0.79

0.10

−0.81

0.10

−2.17

rs943080

chr6

43,826,627

intergenic

C

T

VEGFA

0.73

0.73

0.00

0.76

0.37

0.79

0.99

0.72

−0.06

0.67

−0.92

0.67

−2.46

rs9564692

chr13

31,821,240

intronic

C

T

B3GALTL

0.71

0.71

0.00

0.73

0.14

0.73

0.20

0.70

−0.06

0.69

−0.20

0.73

0.63

  1. CHS Southern Han Chinese, China, CDX Chinese Dai in Xishuangbanna, China, KHV Kinh in Ho Chi Minh City, Vietnam, CHB: Han Chinese in Beijing, China, JPT Japanese in Tokyo in 1000 genome project, KOR Korean Reference Genome data base, Chr chromosome, EAF effect allele frequency, ref. allele reference allele, alt allele alterative allele, P-value: adjusted Fischer’s test assuming 138 hypotheses, statistical significance was set at P < 0.05